These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

473 related items for PubMed ID: 25560939

  • 1. Differential expression of the beta4 neuronal nicotinic receptor subunit affects tolerance development and nicotinic binding sites following chronic nicotine treatment.
    Meyers EE, Loetz EC, Marks MJ.
    Pharmacol Biochem Behav; 2015 Mar; 130():1-8. PubMed ID: 25560939
    [Abstract] [Full Text] [Related]

  • 2. Deletion of the alpha7, beta2, or beta4 nicotinic receptor subunit genes identifies highly expressed subtypes with relatively low affinity for [3H]epibatidine.
    Marks MJ, Whiteaker P, Collins AC.
    Mol Pharmacol; 2006 Sep; 70(3):947-59. PubMed ID: 16728647
    [Abstract] [Full Text] [Related]

  • 3. Deletion of the beta 2 nicotinic acetylcholine receptor subunit alters development of tolerance to nicotine and eliminates receptor upregulation.
    McCallum SE, Collins AC, Paylor R, Marks MJ.
    Psychopharmacology (Berl); 2006 Mar; 184(3-4):314-27. PubMed ID: 16001112
    [Abstract] [Full Text] [Related]

  • 4. Gene targeting demonstrates that alpha4 nicotinic acetylcholine receptor subunits contribute to expression of diverse [3H]epibatidine binding sites and components of biphasic 86Rb+ efflux with high and low sensitivity to stimulation by acetylcholine.
    Marks MJ, Meinerz NM, Drago J, Collins AC.
    Neuropharmacology; 2007 Sep; 53(3):390-405. PubMed ID: 17631923
    [Abstract] [Full Text] [Related]

  • 5. Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells.
    Riganti L, Matteoni C, Di Angelantonio S, Nistri A, Gaimarri A, Sparatore F, Canu-Boido C, Clementi F, Gotti C.
    Br J Pharmacol; 2005 Dec; 146(8):1096-109. PubMed ID: 16273122
    [Abstract] [Full Text] [Related]

  • 6. The subunit composition and pharmacology of alpha-Conotoxin MII-binding nicotinic acetylcholine receptors studied by a novel membrane-binding assay.
    Salminen O, Whiteaker P, Grady SR, Collins AC, McIntosh JM, Marks MJ.
    Neuropharmacology; 2005 Apr; 48(5):696-705. PubMed ID: 15814104
    [Abstract] [Full Text] [Related]

  • 7. Neuronal nicotinic receptor beta2 and beta4 subunits confer large differences in agonist binding affinity.
    Parker MJ, Beck A, Luetje CW.
    Mol Pharmacol; 1998 Dec; 54(6):1132-9. PubMed ID: 9855644
    [Abstract] [Full Text] [Related]

  • 8. Characterization of [(125) I]epibatidine binding and nicotinic agonist-mediated (86) Rb(+) efflux in interpeduncular nucleus and inferior colliculus of beta2 null mutant mice.
    Marks MJ, Whiteaker P, Grady SR, Picciotto MR, McIntosh JM, Collins AC.
    J Neurochem; 2002 Jun; 81(5):1102-15. PubMed ID: 12065623
    [Abstract] [Full Text] [Related]

  • 9. α6β2*-subtype nicotinic acetylcholine receptors are more sensitive than α4β2*-subtype receptors to regulation by chronic nicotine administration.
    Marks MJ, Grady SR, Salminen O, Paley MA, Wageman CR, McIntosh JM, Whiteaker P.
    J Neurochem; 2014 Jul; 130(2):185-98. PubMed ID: 24661093
    [Abstract] [Full Text] [Related]

  • 10. Identification of a novel nicotinic binding site in mouse brain using [(125)I]-epibatidine.
    Whiteaker P, Jimenez M, McIntosh JM, Collins AC, Marks MJ.
    Br J Pharmacol; 2000 Oct; 131(4):729-39. PubMed ID: 11030722
    [Abstract] [Full Text] [Related]

  • 11. Genetic deletion of the adenosine A(2A) receptor prevents nicotine-induced upregulation of α7, but not α4β2* nicotinic acetylcholine receptor binding in the brain.
    Metaxas A, Al-Hasani R, Farshim P, Tubby K, Berwick A, Ledent C, Hourani S, Kitchen I, Bailey A.
    Neuropharmacology; 2013 Aug; 71():228-36. PubMed ID: 23583933
    [Abstract] [Full Text] [Related]

  • 12. The contribution of α4β2 and non-α4β2 nicotinic acetylcholine receptors to the discriminative stimulus effects of nicotine and varenicline in mice.
    de Moura FB, McMahon LR.
    Psychopharmacology (Berl); 2017 Mar; 234(5):781-792. PubMed ID: 28028600
    [Abstract] [Full Text] [Related]

  • 13. In vivo effects of 3-iodocytisine: pharmacological and genetic analysis of hypothermia and evaluation of chronic treatment on nicotinic binding sites.
    Zambrano CA, Marks MJ, Cassels BK, Maccioni RB.
    Neuropharmacology; 2009 Sep; 57(3):332-42. PubMed ID: 19481555
    [Abstract] [Full Text] [Related]

  • 14. Differential regulation of nicotinic acetylcholine receptors in PC12 cells by nicotine and nerve growth factor.
    Avila AM, Dávila-García MI, Ascarrunz VS, Xiao Y, Kellar KJ.
    Mol Pharmacol; 2003 Oct; 64(4):974-86. PubMed ID: 14500754
    [Abstract] [Full Text] [Related]

  • 15. Chronic ethanol treatment decreases [3H]epibatidine and [3H]nicotine binding and differentially regulates mRNA levels of nicotinic acetylcholine receptor subunits expressed in M10 and SH-SY5Y neuroblastoma cells.
    Gorbounova O, Svensson AL, Jönsson P, Mousavi M, Miao H, Hellström-Lindahl E, Nordberg A.
    J Neurochem; 1998 Mar; 70(3):1134-42. PubMed ID: 9489734
    [Abstract] [Full Text] [Related]

  • 16. Roles of nicotinic acetylcholine receptor beta subunits in function of human alpha4-containing nicotinic receptors.
    Wu J, Liu Q, Yu K, Hu J, Kuo YP, Segerberg M, St John PA, Lukas RJ.
    J Physiol; 2006 Oct 01; 576(Pt 1):103-18. PubMed ID: 16825297
    [Abstract] [Full Text] [Related]

  • 17. Differential cross-tolerance to the effects of nicotinic acetylcholine receptor drugs in C57BL/6J mice following chronic varenicline.
    de Moura FB, McMahon LR.
    Behav Pharmacol; 2019 Aug 01; 30(5):412-421. PubMed ID: 30398980
    [Abstract] [Full Text] [Related]

  • 18. Differential regulation of neuronal nicotinic receptor binding sites following chronic nicotine administration.
    Flores CM, Dávila-García MI, Ulrich YM, Kellar KJ.
    J Neurochem; 1997 Nov 01; 69(5):2216-9. PubMed ID: 9349569
    [Abstract] [Full Text] [Related]

  • 19. Subsets of acetylcholine-stimulated 86Rb+ efflux and [125I]-epibatidine binding sites in C57BL/6 mouse brain are differentially affected by chronic nicotine treatment.
    Marks MJ, Rowell PP, Cao JZ, Grady SR, McCallum SE, Collins AC.
    Neuropharmacology; 2004 Jun 01; 46(8):1141-57. PubMed ID: 15111021
    [Abstract] [Full Text] [Related]

  • 20. Mouse beta-TC6 insulinoma cells: high expression of functional alpha3beta4 nicotinic receptors mediating membrane potential, intracellular calcium, and insulin release.
    Ohtani M, Oka T, Badyuk M, Xiao Y, Kellar KJ, Daly JW.
    Mol Pharmacol; 2006 Mar 01; 69(3):899-907. PubMed ID: 16332988
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.